与“Mo“有关的文献报道

mm)], but the 6-mo group had a faster length gain from 9 to 12 mo [difference: 0.9 mm/mo (0.3, 1.5 mm/mo)] and a larger

carbohydrates (%) and utilized fewer carbohydrates after 6 mo of supplementation (P = 0.05). In turn, this shift in fat

bolites in a 3-mo intervention study in postmenopausal women (32), no association was reported in a 6-mo soy-interventi

t loss in the first 2 mo of follow-up (–0.72 compared with –0.31 kg), but after 12 mo of follow-up both gro

ent after 1 mo of nutritional intervention. Significance of normalization of complex I activity after 1 mo of refeedin

nal weight was measured at 6 mo after delivery. Blood samples At infant ages 4 and 10 mo, blood samples were obtained

severe illness at 6 mo but could have become ill by 9 mo, whereas control infants were well at 9 mo. Ethical approval

h length or height at both 9 mo and 10 y of age. The stronger association was seen at 9 mo of age. Furthermore, we foun

up increased further from 3 to 6 mo (14%; P = 0.03). Group differences remained at 6 mo (HP versus LP and control, P = 0

conducted at 4-mo intervals. Duration of exercise progressed from 20 min at baseline to 45 min at 6 mo and the intensi

mo of age has been reported to affect vitamin A status at 1–2 mo but the effect is not sustained to 4–6 mo

、MO 7项的结果影响。现报告如下。 1 对象与方法 1.1 对象 随机抽样在我科健康体检者40例，男27例，女13例，年龄21～55岁。 1.2 检测项目、仪器、试剂 项目：WBC、RBC、Hb、PLT、GR、LY、MO。

3 mo and continued to decline to a minimum of 5.85 kg or 19% below baseline by the end of 9 mo. During the last 6 mo (p

sustained 12 mo after supplement withdrawal and that some residual effects were still evident after 24 mo. At FU1, the

l-time RT-PCR in the 2 treatment groups before and after 2 mo of treatment. A treatment effect (fish oil versus placebo,

, after 5 mo of intervention, and the final screening took place in September–October 2005, after 12 mo of interv

s hemoglobin <110 g/L for 12–24-mo-olds or <111 g/L for 24–36-mo-olds (22). To determine abnormal valu

100 nonstunted infants 6–12 mo of age to receive zinc or placebo daily for 6 mo. Zinc supplementation increased t

bo groups for serum zinc at 6 mo of age and for the difference in serum zinc at 1 and 6 mo of age were tested with analy

nts in protein and carbohydrate groups at baseline, 3 mo, and 6 mo of a strength and conditioning program1 Of the

biweekly, 29.7 mg I monthly, 148.2 mg I every 3 mo, 382 mg I every 6 mo, and 993 mg I yearly) with intermittent potassi

included children aged 0–60 mo inclusive. The inclusion of children aged <24 mo skewed the prevalence data downw

o return to school or work within 2 mo of delivery or to leave the area within 3 mo of delivery were excluded. At the t

raphic data for the 86 infants who completed the entire 12-mo study. There were no significant differences between the g

foxide (DMSO) were obtained from Sigma-Aldrich (St. Louis, MO). All tissue culture reagents were obtained from Invitroge

ype 1-S) was purchased from Sigma Chemical Co. (St. Louis, MO). Other reagents were obtained from Sigma Chemical, Wako P

mo, 8–11 mo, 12–23 mo (1 y), 24–35 mo (2 y), 36–47 mo (3 y), 48–59 mo (4 y), and 60–71 mo

this table: TABLE 5. Values at 0 mo and 6 mo and changes () between 0-mo and 6-mo measurements in the 2 diet groups,

mo of the infants’ lives (6–8 mo) and the second encompassing the ninth, tenth, and eleventh mo (9–11 mo

roup at baseline and after the 3-mo diet1 Biochemical variables After the 3-mo diet (Table 4), plasma total cho

mo. Biochemical indicators were determined at baseline and 12 mo. Cognitive performance was measured at baseline, 6 mo,

a national program; those 12 mo old were given 200 000 IU vitamin A, and those <12 mo old were given 100 000 IU.

mo compared with 6 mo. The authors identified 20 studies comparing exclusive breastfeeding for 6 mo versus 3–4 mo.

lved the longitudinal follow-up of children aged 0–95 mo for clinical malaria episodes and anthropometric measureme

3 mo, 2) after 2–3 mo but by 4–5 mo, 3) after 4–5 mo but by 6–7 mo, and 4) later than 6–7 mo.

nts in protein and carbohydrate groups at baseline, 3 mo, and 6 mo of a strength and conditioning program1

ns 2-mo cyclosporine Perfusion defect reduced 10.5% increase in EF after 3-mo 35.6% increase in EF after 12-mo CCS-

ot complete 9 mo of the trial diet were seen at the 9-mo follow-up and 7 infants who did not complete 9 mo of the trial

mo in the IUS group. This definition of response was a change in hemoglobin, either from 0 to 6 mo or from 0 to 12 mo,